Inogen (INGN) Times Interest Earned (2013 - 2022)

Inogen (INGN) reported Times Interest Earned of -$857.67 for Q3 2022, down 6370.36% year-over-year from $13.68 in Q3 2021, and down 6370.36% quarter-over-quarter from $13.68 in Q3 2021.

Inogen (INGN) Times Interest Earned (2013 - 2022) Analysis & Trends

Inogen (INGN) has 6 years of Times Interest Earned data on file, last reported at -$857.67 in Q3 2022.

  • Times Interest Earned for Q3 2022 came in at -$857.67, down 6370.36% year-over-year; the trailing twelve-month figure through Jun 2023 was -$8538.7 (down 23639.75% YoY), and the FY2016 annual result was $3810.7, up 457.0% from the prior year.
  • Times Interest Earned declined to -$857.67 in Q3 2022 per INGN's latest filing, from $13.68 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $13.68 in Q3 2021 and troughed at -$857.67 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 7.73
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 6.32
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 8.09
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 12.23
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -2.90
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 5.36
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 20.98
10 Inogen 176.23 Mn 81.82 Mn 37.86 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 -857.67
Sep 30, 2021 13.68
Sep 30, 2016 5,397.00
Jun 30, 2016 4,009.50
Mar 31, 2016 1,092.33
Dec 31, 2015 868.50
Sep 30, 2015 742.80
Jun 30, 2015 890.83
Mar 31, 2015 359.71
Dec 31, 2014 159.11
Sep 30, 2014 34.30
Jun 30, 2014 19.52
Mar 31, 2014 11.65
Dec 31, 2013 2.21
Sep 30, 2013 7.84
Jun 30, 2013 25.18
Mar 31, 2013 6.09